Trials / Completed
CompletedNCT03329443
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 490 (actual)
- Sponsor
- Alhasan Mujtaba Abdul-Wahid · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
an interventional study to measure the possible effects of spironolactone ( an aldosterone antagonist) on the incidence of acute kidney injury after coronary angiography
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spironolactone | each patient will receive 200 mg of spironolactone as per his/her angiography premedications |
| DRUG | Placebo Oral Tablet | Each patient will receive a placebo tablet as per his/her angiography premedications |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-04
- First posted
- 2017-11-06
- Last updated
- 2018-09-10
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT03329443. Inclusion in this directory is not an endorsement.